Research programme: bromelain protein isolates - Hawkley Oil & Gas
Alternative Names: CCS; CCZ; ICV 0019; ICV 0026Latest Information Update: 14 Jan 2022
Price :
$50 *
At a glance
- Originator Incitive
- Developer Hawkley Oil & Gas
- Class Proteins
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Graft-versus-host disease; Inflammatory bowel diseases; Rheumatoid arthritis
Most Recent Events
- 19 May 2006 Preclinical trials in Graft-versus-host disease in Australia (unspecified route)
- 19 May 2006 Preclinical trials in Inflammatory bowel disease in Australia (unspecified route)
- 19 May 2006 Preclinical trials in Rheumatoid arthritis in Australia (unspecified route)